Mavacamten for HCM

Mavacamten for HCM  Guest: Jeffrey B. Geske, M.D. (@jeffreygeske) Host: Paul A. Friedman, M.D. (@drpaulfriedman) Joining us today to discuss new treatment approaches for hypertrophic cardiomyopathy (HCM) is Jeffrey B. Geske, M.D., professor of medicine and Cardiologist specializing in imaging at Mayo Clinic in Rochester, Minnesota. Specific topics discussed: What is Mavacamten, how does it work? How has Mavacamten been used in patients with HCM? What is the VALOR-HCM trial? How do you foresee Mavacamten use altering the treatment landscape in HCM? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV. NEW Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.